A three-for-one value opportunity for compelling sectors
This trust invests in compelling sectors that all look attractively priced.

The AVI Global Trust (LSE: AGT) offers investors access to three opportunities at once. The first is family-controlled holding companies. Shares of companies with high ownership by founding families outperform. A recent report by fund managers Pictet found that those with family ownership above 30% outperformed the global market by 46% between 2007 and 2019.
The direct link between ownership and management acts as a powerful incentive to focus on long-term value accretion rather than the short-term dash for glory favoured by all too many hired-hand chief executives.
A new bull market
Then there is Japan. Charles Gave, chairman of Gavekal, the investment research group, points out that “a new bull market in non-financial Japanese equities began sometime between 2012 and 2016, and it probably has a lot further to run. The profits of Japanese companies are in a structural uptrend, Japanese companies have positive cash flow and the amount of cash on their books is close to the market capitalisation of the entire Topix index.”
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Thirdly, note that despite an average discount to net asset value (NAV) of 6% among investment trusts, several still trade on wide discounts despite strong performance records, usually because they don’t fit neatly into conventional investment categories. Eventually, performance should trump the doubts and the discounts then disappear, boosting returns for those prepared to buy early.
AGT spreads its bets between all three areas: 38% of net assets is invested in family-controlled holding companies, 39% in closed-end funds and 33% in Japan, with the 10% overinvestment financed by borrowings. The connection between the three is value; the family-controlled companies trade at large discounts to the sum of their parts, the closed-end funds trade at discounts and the Japanese companies have significant surplus assets. So enthused is Joe Bauernfreund, manager of AGT, about the last that last year he launched a £120m investment trust, AVI Japan Opportunity (AJOT), focused on smaller companies.
In the Japanese small-cap portfolio, “50% of the market value is accounted for by surplus net cash, rising to 94% if listed securities are included”, says Bauernfreund. “This [leaves] the underlying businesses trading on less than three times earnings. These are high-quality businesses with growing earnings and a return on equity of 18%, double that of Japanese smaller companies in general.”
Finding undervalued assets
Both in Japan and generally, Bauernfreund’s strategy is “patient, constructive, behind-the-scenes engagement in companies with undervalued assets”. This does not preclude going public, as AGT did with Fujitec, circulating research detailing “operational and strategic inefficiencies as well as a cumbersome balance sheet and corporate governance issues”. Fujitec was one of the leading contributors to performance in June.
The closed-end holdings include Pershing Square, on a discount of over 30% despite returning 32% in the first half, and private-equity group Oakley Capital. It is on a 37% discount to conservatively valued assets despite plenty of net cash and a return of 4% in the first half.
In the family-controlled section of the portfolio are Investor, the holding company of the Wallenberg family; Christian Dior, controlled by LVMH’s boss Bernard Arnault; Exor, controlled by the Agnelli family; and Godrej Industries, the holding company for three listed Indian firms of which the consumer products one is “the jewel in the crown”. AGT trades at an 11% discount to NAV, which should narrow as the investee businesses perform and their discounts diminish. This makes AGT an excellent counterbalance to the growth-orientated trusts that dominate the performance tables.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Max has an Economics degree from the University of Cambridge and is a chartered accountant. He worked at Investec Asset Management for 12 years, managing multi-asset funds investing in internally and externally managed funds, including investment trusts. This included a fund of investment trusts which grew to £120m+. Max has managed ten investment trusts (winning many awards) and sat on the boards of three trusts – two directorships are still active.
After 39 years in financial services, including 30 as a professional fund manager, Max took semi-retirement in 2017. Max has been a MoneyWeek columnist since 2016 writing about investment funds and more generally on markets online, plus occasional opinion pieces. He also writes for the Investment Trust Handbook each year and has contributed to The Daily Telegraph and other publications. See here for details of current investments held by Max.
-
IonQ offers no quantum of solace
Opinion Quantum computing group IonQ is inefficient, overhyped and overpriced
By Dr Matthew Partridge Published
-
Top-notch Taiwanese companies cashing in on AI
Opinion Eric Chan, investment director and co-manager of the Aberdeen Asian Income Fund, highlights three potential Taiwanese winners in the technology industry
By Eric Chan Published
-
Three top-notch Taiwanese companies cashing in on the advent of AI
Opinion Eric Chan, investment director and co-manager of the Aberdeen Asian Income Fund, highlights three potential Taiwanese winners in the technology industry
By Eric Chan Published
-
Weight-loss drugs could revolutionise the economy – the investments to buy now
The new generation of weight-loss drugs are a boon for the overweight, but they also promise to change our relationship with food and revolutionise the economy
By Dr Matthew Partridge Published
-
Find tomorrow’s Asian giants while they are still smaller companies
Opinion Nitin Bajaj, portfolio manager of the Fidelity Asian Values trust, picks three Asian companies to invest in.
By Nitin Bajaj Published
-
AI will maintain Moody’s market lead, says Stephen Connolly
Opinion Veteran data provider Moody's has adapted well to the modern world, and is one of Warren Buffett’s longest-held investments
By Stephen Connolly Published
-
Is BlackRock World Mining gearing for a recovery?
Opinion After a frustrating year, BlackRock World Mining is positioned for growth and to capitalise on the sector's recovery
By Rupert Hargreaves Published
-
Should you limit exposure to US tech stocks?
An end to the AI boom would shake both US funds and global trackers. Here’s one way to trim exposure to US tech stocks
By Cris Sholto Heaton Published
-
The mystery of America’s gold and why an audit matters
How much gold does the US actually have? Dominic Frisby explains why it matters
By Dominic Frisby Published
-
Art vs AI: artists’ uprising takes on the bots
AI performs impressively, but it’s all based on human work that was taken without payment. The government thinks this is fine. Copyright holders beg to differ
By Simon Wilson Published